161 related articles for article (PubMed ID: 1639406)
1. Mapping of the motor neuron degeneration (Mnd) gene, a mouse model of amyotrophic lateral sclerosis (ALS).
Messer A; Plummer J; Maskin P; Coffin JM; Frankel WN
Genomics; 1992 Jul; 13(3):797-802. PubMed ID: 1639406
[TBL] [Abstract][Full Text] [Related]
2. Genetics of primary and timing effects in the mnd mouse.
Messer A; Plummer J; MacMillen MC; Frankel WN
Am J Med Genet; 1995 Jun; 57(2):361-4. PubMed ID: 7668363
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
[TBL] [Abstract][Full Text] [Related]
4. Accelerated and widespread neuronal loss occurs in motor neuron degeneration (mnd) mice expressing a neurofilament-disrupting transgene.
Plummer J; Peterson A; Messer A
Mol Cell Neurosci; 1995 Dec; 6(6):532-43. PubMed ID: 8742270
[TBL] [Abstract][Full Text] [Related]
5. TDP-43 in differential diagnosis of motor neuron disorders.
Dickson DW; Josephs KA; Amador-Ortiz C
Acta Neuropathol; 2007 Jul; 114(1):71-9. PubMed ID: 17569066
[TBL] [Abstract][Full Text] [Related]
6. Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation.
Zhang B; Tu P; Abtahian F; Trojanowski JQ; Lee VM
J Cell Biol; 1997 Dec; 139(5):1307-15. PubMed ID: 9382875
[TBL] [Abstract][Full Text] [Related]
7. A novel locus for distal motor neuron degeneration maps to chromosome 7q34-q36.
Gopinath S; Blair IP; Kennerson ML; Durnall JC; Nicholson GA
Hum Genet; 2007 Jun; 121(5):559-64. PubMed ID: 17354000
[TBL] [Abstract][Full Text] [Related]
8. Increase of glial fibrillary acidic protein fragments in the spinal cord of motor neuron degeneration mutant mouse.
Fujita K; Yamauchi M; Matsui T; Titani K; Takahashi H; Kato T; Isomura G; Ando M; Nagata Y
Brain Res; 1998 Feb; 785(1):31-40. PubMed ID: 9526038
[TBL] [Abstract][Full Text] [Related]
9. The kinesin light chain gene: its mapping and exclusion in mouse and human forms of inherited motor neuron degeneration.
Hafezparast M; Witherden A; Nicholson S; Bermingham N; Mackin J; ten Asbroek A; Ball S; Peters J; Baas F; Martin JE; Fisher EM
Neurosci Lett; 1999 Sep; 273(1):49-52. PubMed ID: 10505649
[TBL] [Abstract][Full Text] [Related]
10. An early-onset congenic strain of the motor neuron degeneration (mnd) mouse.
Messer A; Manley K; Plummer JA
Mol Genet Metab; 1999 Apr; 66(4):393-7. PubMed ID: 10191135
[TBL] [Abstract][Full Text] [Related]
11. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient.
Niessen HG; Angenstein F; Sander K; Kunz WS; Teuchert M; Ludolph AC; Heinze HJ; Scheich H; Vielhaber S
Exp Neurol; 2006 Oct; 201(2):293-300. PubMed ID: 16740261
[TBL] [Abstract][Full Text] [Related]
12. The Overexpression of TDP-43 Protein in the Neuron and Oligodendrocyte Cells Causes the Progressive Motor Neuron Degeneration in the SOD1 G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
Lu Y; Tang C; Zhu L; Li J; Liang H; Zhang J; Xu R
Int J Biol Sci; 2016; 12(9):1140-9. PubMed ID: 27570488
[TBL] [Abstract][Full Text] [Related]
13. Onset and progression of motor deficits in motor neuron degeneration (mnd) mice are unaltered by the glycine/NMDA receptor antagonist L-701,324 or the MAO-B inhibitor R(-)-deprenyl.
Boyce S; Webb JK; Carlson E; Rupniak NM; Hill RG; Martin JE
Exp Neurol; 1999 Jan; 155(1):49-58. PubMed ID: 9918704
[TBL] [Abstract][Full Text] [Related]
14. Animal models for motor neuron disease.
Green SL; Tolwani RJ
Lab Anim Sci; 1999 Oct; 49(5):480-7. PubMed ID: 10551448
[TBL] [Abstract][Full Text] [Related]
15. Probable exclusion of the cortexin-encoding gene as a candidate for mouse neurological mutants: nervous, tottering and motor neuron degeneration.
Horvath DH; Watson JB; Travis GH
Gene; 1996 Jun; 171(2):305-6. PubMed ID: 8666294
[TBL] [Abstract][Full Text] [Related]
16. Zebrafish models of human motor neuron diseases: advantages and limitations.
Babin PJ; Goizet C; Raldúa D
Prog Neurobiol; 2014 Jul; 118():36-58. PubMed ID: 24705136
[TBL] [Abstract][Full Text] [Related]
17. The future of motor neuron disease: the challenge is in the genes.
Veldink JH; Van den Berg LH; Wokke JH
J Neurol; 2004 Apr; 251(4):491-500. PubMed ID: 15083302
[TBL] [Abstract][Full Text] [Related]
18. CNTF overproduction hastens onset of symptoms in motor neuron degeneration (mnd) mice.
Winter CG; Saotome Y; Saotome I; Hirsh D
J Neurobiol; 1996 Nov; 31(3):370-8. PubMed ID: 8910794
[TBL] [Abstract][Full Text] [Related]
19. Mutant PFN1 causes ALS phenotypes and progressive motor neuron degeneration in mice by a gain of toxicity.
Yang C; Danielson EW; Qiao T; Metterville J; Brown RH; Landers JE; Xu Z
Proc Natl Acad Sci U S A; 2016 Oct; 113(41):E6209-E6218. PubMed ID: 27681617
[TBL] [Abstract][Full Text] [Related]
20. CSF glial markers correlate with survival in amyotrophic lateral sclerosis.
Süssmuth SD; Sperfeld AD; Hinz A; Brettschneider J; Endruhn S; Ludolph AC; Tumani H
Neurology; 2010 Mar; 74(12):982-7. PubMed ID: 20308682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
